Article Details

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased ... - Yahoo Finance

Retrieved on: 2024-09-30 19:06:23

Tags for this article:

Click the tags to see associated articles and topics

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased ... - Yahoo Finance. View article details on hiswai:

Excerpt

Truist Securities raised the price target for Corcept Therapeutics Incorporated (NASDAQ:CORT) and cites continued momentum in Korlym sales more ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up